Bausch Health
332 hedge funds and large institutions have $4.59B invested in Bausch Health in 2018 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 84 increasing their positions, 105 reducing their positions, and 52 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 8 → 12 (+4)
42% more first-time investments, than exits
New positions opened: 74 | Existing positions closed: 52
9% more capital invested
Capital invested by funds: $4.2B → $4.59B (+$392M)
6.78% more ownership
Funds ownership: 44.19% → 50.97% (+6.8%)
7% more funds holding
Funds holding: 311 → 332 (+21)
20% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 105
52% less call options, than puts
Call options by funds: $492M | Put options by funds: $1.02B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$173M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$134M |
| 3 |
GCM
Glenview Capital Management
New York
|
+$80.8M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$53.3M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$49.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$50.2M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$20.9M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$20.6M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$20.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$18.1M |
BHC Hedge Fund Activity: Q3 2018 in Review
332 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2018, worth a combined $4.59B — up 9.3% from $4.2B a quarter earlier.
Buyers outnumbered sellers: 74 funds opened new BHC positions and 52 closed out — a net gain of 22 holders — while 84 added to existing stakes and 105 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $173M. The largest seller was Renaissance Technologies, cutting an estimated $50.2M.
- 332 institutional investors held Bausch Health (BHC) as of Q3 2018, up from 311 in Q2 2018.
- Funds reported $4.59B of Bausch Health stock for Q3 2018, up 9.3% quarter-over-quarter.
- 74 funds opened new Bausch Health positions in Q3 2018 and 52 closed out, a net change of +22 holders.
- The largest Bausch Health buyer in Q3 2018 was Wellington Management Group, an estimated $173M added.
- The largest Bausch Health seller in Q3 2018 was Renaissance Technologies, an estimated $50.2M sold.
Based on aggregated 13F filings for Q3 2018.